Major China probiotics firm Beijing Scitop Bio-Tech is to list publicly on the Shenzhen Stock Exchange, with the bulk of the investment received set to be channelled to the construction of a R&D centre.
In light of an imminent $8m IPO, manufacturer Australian Nutrition & Sports (ANS) says it will focus on building its brand in its home nation and the China market before going down the daigou route.
China-based dairy and infant formula specialist Feihe International is said to be reviving its plans for a Hong Kong IPO that could raise up to US$1bn, signifying the firm's second attempt at an IPO.